Evaluating a new scan for detecting coronary artery disease
Evaluation of Diagnostic Accuracy of MCG Scan in Suspected Coronary Artery Disease
This study is testing a new, quick and safe heart scan to see if it can accurately detect serious heart problems in patients who have chest pain and are already scheduled for a standard heart procedure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 908 (estimated) |
| Ages | 19 Years to 80 Years |
| Sex | All |
| Sponsor | Amcg Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 2 sites (Seoul, Eunpyeong-gu and 1 other locations) |
| Trial ID | NCT05825911 on ClinicalTrials.gov |
What this trial studies
This multicenter observational trial aims to assess the diagnostic accuracy of magnetocardiography (MCG) scans in identifying significant coronary artery disease (CAD) compared to the standard coronary arteriography (CAG). Patients experiencing chest pain and scheduled for CAG will be invited to participate by undergoing a non-invasive, radiation-free MCG scan prior to their CAG procedure. The MCG scan utilizes a 96 channel superconducting quantum interference device (SQUID) and takes less than ten minutes to complete. The results from the MCG scan will be compared with those from cardiac SPECT stress tests and CAG, with follow-up for major adverse cardiac events (MACE) occurring over 30 days.
Who should consider this trial
Good fit: Ideal candidates are adults over 19 years old who are presenting for coronary arteriography due to chest pain.
Not a fit: Patients with implanted cardiac devices, certain arrhythmias, or acute coronary syndrome may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a safer, quicker, and more accurate method for diagnosing coronary artery disease.
How similar studies have performed: Previous studies have indicated high diagnostic accuracy for stress MCG scans in identifying symptomatic CAD, suggesting a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over 19 years of age at the time of enrollment * Patient presenting for CAG * Consents to having an MCG scan study Exclusion Criteria: * Patients unable to fit into MCG scan device * Patients with implanted cardiac pacemakers/defibrillators * Atrial fibrillation with rapid ventricular response * Patients with other sustained or incessant arrhythmias * Presence clinical suspicious of any acute coronary syndrome
Where this trial is running
Seoul, Eunpyeong-gu and 1 other locations
- The Catholic University of Korea, Eunpyeong St. Mary's Hospital — Seoul, Eunpyeong-gu, South Korea (Recruiting)
- Gachon University Gil Medical Center — Incheon, Namdong-gu, South Korea (Recruiting)
Study contacts
- Study coordinator: Hoseong Lee Deputy general manager
- Email: lhs@amcg.kr
- Phone: +82-02-598-8001
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.